Related content

Relationship between the oestradiol/oocyte ratio and the outcome of assisted reproductive technology cycles with gonadotropin releasing hormone agonist

By Var Turgut   Tonguc Esra   Dogan Muammer   Mollamahmutoglu Leyla  

Gynecological Endocrinology, Vol. 27, Iss. 8, 2011-08 ,pp. : 558-561

Informa Healthcare

Access to resources Recommend Favorite

Bone resorption starts at 14 days of treatment with gonadotropin-releasing hormone agonist in in vitro fertilization cycles

By Yilmaz H   Ozgur K   Isikoglu M   Sonmez C   Uner M  

Gynecological Endocrinology, Vol. 19, Iss. 1, 2004-07 ,pp. : 40-46

Informa Healthcare

Access to resources Recommend Favorite

Effect of gonadotropin-releasing hormone agonist and antagonist on steroidogenesis of low responders undergoing in vitro fertilization

By Mohamed Kamel Abdelhakim   Davies William   Lashen Hany  

Gynecological Endocrinology, Vol. 22, Iss. 2, 2006-02 ,pp. : 57-62

Informa Healthcare

Access to resources Recommend Favorite

Reducing the dose of gonadotrophin-releasing hormone agonist on starting ovarian stimulation: effect on ovarian response and in-vitro fertilization outcome

By Elgendy M   Afnan M  

Human Reproduction, Vol. 13, Iss. 9, 1998-09 ,pp. : 2382-2385

Oxford University Press

Access to resources Recommend Favorite

Gonadotropin releasing hormone agonist and levonorgestrel-intrauterine device followed by in vitro fertilization program as management strategy for an infertile endometrial cancer patient: a case report

By Nucera Giuseppe   Mandato Vincenzo Dario   Gelli Maria Carolina   Palomba Stefano   La Sala Giovanni Battista  

Gynecological Endocrinology, Vol. 29, Iss. 3, 2013-03 ,pp. : 219-221

Informa Healthcare

Access to resources Recommend Favorite